Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpecGx is a leading developer and manufacturer of specialty generic pharmaceuticals and active pharmaceutical ingredients (APIs), operating as a subsidiary of Mallinckrodt Pharmaceuticals. The company is one of the largest manufacturers of bulk acetaminophen in the world and a significant producer of controlled substances, including opioid analgesics and addiction treatment medications. SpecGx maintains a vertically integrated supply chain, encompassing everything from API synthesis to finished dosage form manufacturing. Its operations are primarily based in the United States, with major facilities in Missouri, North Carolina, and New York. The company plays a critical role in the supply of essential generic medicines while navigating complex regulatory and legal landscapes associated with controlled substances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Specgx.